Psychiatry & Neurology Doctors in Jefferson Valley, NY Accepting Medicare

2 Psychiatry & Neurology doctors found. Showing 1 - 2

Sylvain Nakkab, M.D. Psychiatry & Neurology - Child & Adolescent Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 3651 Hill Blvd, Jefferson Valley, NY 10535 Phone: 914-962-0688    Fax: 914-243-5895

Dr. Myrna Hernandez, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 3651 Hill Blvd, Jefferson Valley, NY 10535 Phone: 914-962-0688    Fax: 914-243-5895

News Archive

PathMaker Neurosystems receives 2016 Universal Biotech Innovation Prize

PathMaker Neurosystems, a clinical-stage neurotechnology company developing non-invasive neurotherapy systems to treat neuromotor disorders, has been named as the Recipient of the Universal Biotech Innovation Prize 2016 in the global competition that offers "a glimpse of the future of life sciences."

Wolverine Venture Fund participates in $8M series A round of financing for Delphinus Medical Technologies

The Wolverine Venture Fund (WVF), managed by The Samuel Zell & Robert H. Lurie Institute for Entrepreneurial Studies at the University of Michigan Ross School of Business, today announced participation in an $8 million series A round of financing for Delphinus Medical Technologies, Inc.

Screening tool may help predict post-surgical complications in older cancer patients

As people age, cancer becomes an increasing health concern. Solid cancer tumors are cancers that don't affect the blood and instead form tumors, or growths of abnormal cells in certain parts of the body. These solid cancer tumors mainly impact people who are 65 and older.

Early genetic rescue may be a potential therapy in autism spectrum disorder

A mouse study by Craig Powell, M.D., Ph.D., and colleagues suggests that early genetic rescue may be a potential therapy in autism spectrum disorder or ASD.

TCAD therapy active and synergistic against drug resistant influenza virus strains

Adamas Pharmaceuticals, Inc., a privately held company, reported today on the publication of results from a preclinical study that demonstrated the synergistic effects of triple combination antiviral drug (TCAD) therapy against multiple strains of seasonal, pandemic, and avian influenza A (H1N1, H3N2 and H5N1) virus, including three strains of amantadine resistant pandemic H1N1 and two strains of oseltamivir resistant seasonal H1N1.

Read more Medical News

› Verified 1 days ago